Influenza is a common respiratory pathogen causing both seasonal and pandemic disease. Influenza infection predisposes the host to secondary bacterial infection of the respiratory tract, which is a major cause of both morbidity and mortality in flu-related disease. In this review, we will discuss innate and adaptive antiviral responses during influenza infection, and review how these responses modulate protective immunity against secondary bacterial pathogens of the lung. Specific emphasis will be placed on implications of bacterial superinfection and mechanisms involved.
Get full access to this article
View all access options for this article.
References
1.
AldridgeJRJr., MoseleyCE, BoltzDA, NegovetichNJ, ReynoldsC, FranksJ, BrownSA, DohertyPC, WebsterRG, ThomasPG. 2009. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci U S A, 106:5306–5311.
2.
AnkN, IversenMB, BartholdyC, StaeheliP, HartmannR, JensenUB, Dagnaes-HansenF, ThomsenAR, ChenZ, HaugenHothers2008. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol, 180:2474–2485.
3.
AvadhanulaV, RodriguezCA, DevincenzoJP, WangY, WebbyRJ, UlettGC, AddersonEE. 2006. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol, 80:1629–1636.
4.
BhatiaA, KastRE. 2007. How influenza's neuraminidase promotes virulence and creates localized lung mucosa immunodeficiency. Cell Mol Biol Lett, 12:111–119.
5.
BiswasSK, BistP, DhillonMK, KajijiT, Del FresnoC, YamamotoM, Lopez-CollazoE, AkiraS, TergaonkarV. 2007. Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance. J Immunol, 179:4083–4092.
6.
BrincksEL, KatewaA, KucabaTA, GriffithTS, LeggeKL. 2008. CD8 T cells utilize TRAIL to control influenza virus infection. J Immunol, 181:4918–4925.
7.
Broug-HolubE, ToewsGB, van IwaardenJF, StrieterRM, KunkelSL, PaineR3rd, StandifordTJ. 1997. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: Elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect Immun, 65:1139–1146.
8.
ChangYS, van HalSJ, SpencerPM, GosbellIB, CollettPW. 2010. Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the “PROTECT” phase of the pandemic response. Med J Aust, 192:90–93.
9.
CroweCR, ChenK, PociaskDA, AlcornJF, KrivichC, EnelowRI, RossTM, WitztumJL, KollsJK. 2009. Critical role of IL-17RA in immunopathology of influenza infection. J Immunol, 183:5301–5310.
10.
CundellDR, GerardNP, GerardC, Idanpaan-HeikkilaI, TuomanenEI. 1995. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature, 377:435–438.
11.
CunhaBA. 2004. Influenza: Historical aspects of epidemics and pandemics. Infect Dis Clin North Am, 18:141–155.
12.
de JongMD, SimmonsCP, ThanhTT, HienVM, SmithGJ, ChauTN, HoangDM, ChauNV, KhanhTH, DongVCothers2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med, 12:1203–1207.
13.
DengJC, ChengG, NewsteadMW, ZengX, KobayashiK, FlavellRA, StandifordTJ. 2006. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J Clin Invest, 116:2532–2542.
14.
DengJC, StandifordTJ. 2005. The systemic response to lung infection. Clin Chest Med, 26:1–9.
15.
EhrhardtC, SeyerR, HrinciusER, EierhoffT, WolffT, LudwigS. 2010. Interplay between influenza A virus and the innate immune signaling. Microbes Infect, 12:81–87.
16.
EngelichG, WhiteM, HartshornKL. 2001. Neutrophil survival is markedly reduced by incubation with influenza virus and Streptococcus pneumoniae: Role of respiratory burst. J Leukoc Biol, 69:50–56.
17.
Fernandez-SesmaA. 2007. The influenza virus NS1 protein: Inhibitor of innate and adaptive immunity. Infect Disord Drug Targets, 7:336–343.
18.
GaffenSL. 2008. An overview of IL-17 function and signaling. Cytokine, 43:402–407.
19.
HashimotoY, MokiT, TakizawaT, ShiratsuchiA, NakanishiY. 2007. Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. J Immunol, 178:2448–2457.
20.
HeroldS, SteinmuellerM, von WulffenW, CakarovaL, PintoR, PleschkaS, MackM, KuzielWA, CorazzaN, BrunnerTothers2008. Lung epithelial apoptosis in influenza virus pneumonia: The role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med, 205:3065–3077.
21.
HussellT, WilliamsA. 2004. Menage a trois of bacterial and viral pulmonary pathogens delivers coup de grace to the lung. Clin Exp Immunol, 137:8–11.
22.
ImaiY, KubaK, NeelyGG, Yaghubian-MalhamiR, PerkmannT, van LooG, ErmolaevaM, VeldhuizenR, LeungYH, WangHothers2008. Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell, 133:235–249.
23.
JainS, KamimotoL, BramleyAM, SchmitzAM, BenoitSR, LouieJ, SugermanDE, DruckenmillerJK, RitgerKA, ChughRothers2009. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med, 361:1935–1944.
24.
JakabGJ. 1981. Mechanisms of virus-induced bacterial superinfections of the lung. Clin Chest Med, 2:59–66.
25.
KobayashiK, HernandezLD, GalanJE, JanewayCAJr., MedzhitovR, FlavellRA. 2002. IRAK-M is a negative regulator of toll-like receptor signaling. Cell, 110:191–202.
26.
Le GofficR, PothlichetJ, VitourD, FujitaT, MeursE, ChignardM, Si-TaharM. 2007. Cutting edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol, 178:3368–3372.
27.
LeVineAM, KoeningsknechtV, StarkJM. 2001. Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. J Virol Methods, 94:173–186.
28.
LindenmannJ, BurkeDC, IsaacsA. 1957. Studies on the production, mode of action and properties of interferon. Br J Exp Pathol, 38:551–562.
29.
LittmanDR, RudenskyAY. 2010. Th17 and regulatory T cells in mediating and restraining inflammation. Cell, 140:845–858.
30.
LouieJK, AcostaM, WinterK, JeanC, GavaliS, SchechterR, VugiaD, HarrimanK, MatyasB, GlaserCAothers2009. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA, 302:1896–1902.
31.
LowenAC, MubarekaS, TumpeyTM, Garcia-SastreA, PaleseP. 2006. The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci U S A, 103:9988–9992.
32.
MainesTR, SzretterKJ, PerroneL, BelserJA, BrightRA, ZengH, TumpeyTM, KatzJM. 2008. Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev, 225:68–84.
33.
McCullersJA. 2006. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev, 19:571–582.
34.
McCullersJA, RehgJE. 2002. Lethal synergism between influenza virus and Streptococcus pneumoniae: Characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis, 186:341–350.
35.
McGillJ, HeuselJW, LeggeKL. 2009. Innate immune control and regulation of influenza virus infections. J Leukoc Biol, 86:803–812.
36.
McGillJ, Van RooijenN, LeggeKL. 2010. IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection. J Exp Med, 207:521–534.
37.
McKinstryKK, StruttTM, BuckA, CurtisJD, DibbleJP, HustonG, TigheM, HamadaH, SellS, DuttonRWothers2009. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol, 182:7353–7363.
38.
McMurryJA, JohanssonBE, De GrootAS. 2008. A call to cellular & humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A. Hum Vaccine, 4:148–157.
39.
McNameeLA, HarmsenAG. 2006. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect Immun, 74:6707–6721.
PittetLA, Hall-StoodleyL, RutkowskiMR, HarmsenAG. 2010. Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. Am J Respir Cell Mol Biol, 42:450–460.
44.
PlotkowskiMC, PuchelleE, BeckG, JacquotJ, HannounC. 1986. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. Am Rev Respir Dis, 134:1040–1044.
45.
PriceGE, Gaszewska-MastarlarzA, MoskophidisD. 2000. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice. J Virol, 74:3996–4003.
46.
RamphalR, FischlschweigerW, ShandsJWJr., SmallPAJr.1979. Murine influenzal tracheitis: A model for the study of influenza and tracheal epithelial repair. Am Rev Respir Dis, 120:1313–1324.
47.
SatohT, KatoH, KumagaiY, YoneyamaM, SatoS, MatsushitaK, TsujimuraT, FujitaT, AkiraS, TakeuchiO. 2010. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A, 107:1512–1517.
SekiM, HigashiyamaY, TomonoK, YanagiharaK, OhnoH, KanekoY, IzumikawaK, MiyazakiY, HirakataY, MizutaYothers2004. Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa. Clin Exp Immunol, 137:35–40.
50.
SekiM, KohnoS, NewsteadMW, ZengX, BhanU, LukacsNW, KunkelSL, StandifordTJ. 2010. Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia. J Immunol, 184:1410–1418.
51.
ShahangianA, ChowEK, TianX, KangJR, GhaffariA, LiuSY, BelperioJA, ChengG, DengJC. 2009. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest, 119:1910–1920.
52.
SmallCL, ShalerCR, McCormickS, JeyanathanM, DamjanovicD, BrownEG, ArckP, JordanaM, KaushicC, AshkarAAothers2010. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J Immunol, 184:2048–2056.
53.
SmithMW, SchmidtJE, RehgJE, OrihuelaCJ, McCullersJA. 2007. Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. Comp Med, 57:82–89.
54.
SpeshockJL, Doyon-RealeN, RabahR, NeelyMN, RobertsPC. 2007. Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3. Infect Immun, 75:3102–3111.
55.
StandifordTJ, StrieterRM, LukacsNW, KunkelSL. 1995. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol, 155:2222–2229.
56.
StegemannS, DahlbergS, KrogerA, GerekeM, BruderD, Henriques-NormarkB, GunzerM. 2009. Increased susceptibility for superinfection with Streptococcus pneumoniae during influenza virus infection is not caused by TLR7-mediated lymphopenia. PLoS One, 4:e4840.
57.
SteinhauserML, HogaboamCM, KunkelSL, LukacsNW, StrieterRM, StandifordTJ. 1999. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J Immunol, 162:392–399.
58.
SunK, MetzgerDW. 2008. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med, 14:558–564.
59.
TakeuchiO, AkiraS. 2010. Pattern recognition receptors and inflammation. Cell, 140:805–820.
60.
TamuraS, KurataT. 2004. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn J Infect Dis, 57:236–247.
61.
TilgH, MoschenAR, KaserA. 2009. Suppression of interleukin-17 by type I interferons: A contributing factor in virus-induced immunosuppression?Eur Cytokine Netw, 20:1–6.
62.
van der MeerFJ, OrselK, BarkemaHW. 2010. The new influenza A H1N1 virus: Balancing on the interface of humans and animals. Can Vet J, 51:56–62.
63.
van der SluijsKF, van EldenLJ, NijhuisM, SchuurmanR, FlorquinS, ShimizuT, IshiiS, JansenHM, LutterR, van der PollT. 2006. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. Am J Physiol Lung Cell Mol Physiol, 290:L194–L199.
64.
van der SluijsKF, van EldenLJ, NijhuisM, SchuurmanR, PaterJM, FlorquinS, GoldmanM, JansenHM, LutterR, van der PollT. 2004. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol, 172:7603–7609.
65.
WadowskyRM, MietznerSM, SkonerDP, DoyleWJ, FiremanP. 1995. Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects. Infect Immun, 63:1153–1157.
66.
WangJ, Oberley-DeeganR, WangS, NikradM, FunkCJ, HartshornKL, MasonRJ. 2009. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J Immunol, 182:1296–1304.
67.
WareingMD, SheaAL, InglisCA, DiasPB, SarawarSR. 2007. CXCR2 is required for neutrophil recruitment to the lung during influenza virus infection, but is not essential for viral clearance. Viral Immunol, 20:369–378.
